Nitric oxide primes pancreatic β cells for Fas-mediated destruction in insulin-dependent diabetes mellitus

Journal of Experimental Medicine

Volumn 186, Issue 8, 1997, Pages 1193-1200

  Stassi, Giorgio ^a,d   De Maria, Ruggero ^b   Trucco, Giuliana ^a,c   Rudert, William ^a   Testi, Roberto ^b   Galluzzo, Aldo ^d   Giordano, Carla ^d,e   Trucco, Massimo ^a,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; HLA ANTIGEN; INTERLEUKIN 1BETA; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; RECEPTOR;

APOPTOSIS; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSIS; ETIOLOGY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD95; APOPTOSIS; CELL MOVEMENT; CHILD; DIABETES MELLITUS, TYPE 1; FAS LIGAND PROTEIN; FEMALE; HUMANS; INTERLEUKIN-1; ISLETS OF LANGERHANS; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; NITRIC OXIDE; T-LYMPHOCYTE SUBSETS;

EID: 0030731917     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.8.1193     Document Type: Article

References (26)

1. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
2. Krammer, P.H. 1996. The CD95(APO-1/Fas) receptor/ ligand system: death signals and disease. Cell Death Differ. 3: 159-160.
3. Adachi, M., S. Suematsu, T. Kondo, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1995. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Med. 11:294-299.
4. Bach, J.F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:516-542.
5. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (Lond.). 370:650-652.
6. Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (Wash. DC). 265:528-530.
7. Leithauser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Bruderlein, C. Henne, A. Schmidt, K.M. Debatin, P.H. Krammer, and P. Moller. 1993. Constitutive and induced expression of Apo-1, a member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415-429.
8. Stassi, G., M. Todaro, P. Richiusa, M. Giordano, A. Mattina, S. Sbriglia, A. Lo Monte, G. Buscemi, A. Galluzzo, and C. Giordano. 1995. Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human β-cells sorted by flow-cytometry and cultured in vitro. Transplant. Proc. 27:3271-3275.
9. Chervonsky, A.V., Y. Wang, F.S. Wong, I. Visintin, R.A. Flavell, C.A. Janeway, and L.A. Matis. 1997. The role of Fas in autoimmune diabetes. Cell. 89:17-24.
10. Kolb, H., and V. Kolb-Bachofen. 1992. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol. Today. 13: 157-160.
11. Reddy, S., S. Kaill, C.A. Poole, and J. Ross. 1997. Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: a light and confocal microscopical study of its ontogeny, co-localization and up-regulation following cytokine administration. Histochem. J. 29:53-64.
12. Rabinovitch, A., W.L. Suarez-Pinzon, O. Sorensen, and R.C. Bleackley. 1996. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS expressing cells and relationships to cytokines expressed in the islets. Endocrinology. 137:1907-1912.
13. Kolb, H., V. Kolb-Bachofen, and B. Roep. 1995. Autoimmune versus inflammatory type I diabetes: a controversy? Immunol. Today. 16:170-172.
14. Conrad, B., E. Weidmann, G. Trucco, W.A. Rudert, R. Behboo, C. Ricordi, H. Rodriquez-Rilo, D. Finegold, and M. Trucco. 1994. Evidence of superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature (Lond.). 371:351-354.
15. Trucco, M. 1992. To be, or not to be Asp 57, that is the question. Diabetes Care. 15:705-715.
16. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
17. MacMicking, J., Q. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
18. Palmer, R.M.J., D.D. Rees, D.S. Ashton, and S. Moncada. 1988. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. BBRC (Biochemical and Biophysical Research Communications). 153:1251-1256.
19. Sakuma, I., D.J. Stuehr, S.S. Gross, C. Nathan, and R. Levi. 1988. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA. 85: 8664-8667.
20. Giordano, C., G. Stassi, R. De Maria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi, and A. Galluzzo. 1997. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science (Wash. DC). 275:960-963.
21. Abbas, A.K. 1996. Die and let live: eliminating dangerous lymphocytes. Cell. 85:291-297.
22. De Maria, R., M. Boirivant, M.G. Cifone, P. Roncaioli, M. Hahne, J. Tschopp, F. Pallone, A. Santoni, and R. Testi. 1996. Functional expression of Fas and Fas ligand on human gut lamina propria lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J. Clin. Invest. 97:316-322.
23. Van Parijs, L., and A.K. Abbas. 1996. Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8:355-361.
24. Kurrer, M.O., S.V. Pakala, H.L. Hanson, and J.D. Katz. 1997. β cell apoptosis in T cell-mediated autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 94:213-218.
25. Roep, B.O. 1996. T-cell responses to autoantigens in IDDM: the search for the holy grail. Diabetes. 45:1147-1156.
26. Corbett, J.A., J.L. Wang, M.A. Sweetland, J.R. Lancaster, and M.L. McDaniel. 1992. Interleukin-1 β induces the formation of nitric oxide by β-cells purified from rodent islets ot Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J. Clin. Invest. 90:2384-2391.